Skip to main content
Fig. 2 | Orphanet Journal of Rare Diseases

Fig. 2

From: A review of the clinical outcomes in idursulfase-treated and untreated Filipino patients with mucopolysaccharidosis type II: data from the local lysosomal storage disease registry

Fig. 2

Height of treated and untreated MPS II patients at baseline (0) year 1 and year 2 of follow up as classified in to age groups. a Group 1: aged < 6 years at start of ERT or at time of diagnosis, b Group 2: aged 6–10 years at start of ERT or at time of diagnosis. c Group 3: aged > 10 years at start of ERT or at time of diagnosis

Back to article page